NeurologyLive Friday 5 — August 14, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 14, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Could Hyperbaric Oxygen Therapy Improve Cognitive Function in Dementia?
Shai Efrati, MD, director, Sagol Center for Hyperbaric Medicine and Research, Yitzhak Shamir Medical Center, offers insight into the attempt to regenerate injured tissue in the brain as a way to potentially treat Alzheimer disease and dementia.
2: Podcast: A New Approval: The SMA Treatment Landscape
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Richard Finkel, MD, on the recent approval of risdiplam for SMA.
3: Peer Exchange: Advice for Treatment of DMD
Expert neurologists Crystal Proud, MD; Emma Ciafaloni, MD; and Amy Harper, MD, provide advice for community physicians treating patients with Duchenne muscular dystrophy.
4: Personal Social Networks Associated With Physical Function in Multiple Sclerosis
Larger social network effective size correlated with better physical function, while network constraint correlated with worse physical function in those with multiple sclerosis.
5: GammaCore nVNS Device Offers Versatile Option in Migraine and Cluster Headache
A literature and clinical evidence review suggests that the gammaCore device (electroCore) is safe and effective for the treatment of cluster headache and migraine, and carries potential to treat more.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
